Should flagging medical tourism alarm Raffles Medical?

There were fewer foreign patients in Q3.

According to OCBC, Raffles Medical remains a strong contender against its regional competitors despite flagging medical tourism.

Although the company recorded a lower volume of patients from Indonesia and Russia, it witnessed higher intensity cases such as the company’s bone marrow programme. So while it remains possible that some patients opt for other hospitals for treatments with cheaper costs, the company still caters to a premium segment of patients.

Further, the company has expended effort and resources in diversifying, as evidenced by its acquisition of International SOS (MC Holdings) Pte Ltd as well as its new centre in Japan.

OCBC also noted that Raffles Medical’s share price tumbled 16.6% from its 52-week high of $4.99 in July, or by 5.2% post Q3 results.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia